Sex-specific differences in access and response to medical and device therapies in heart failure: State of the art.
Prog Cardiovasc Dis
; 63(5): 640-648, 2020.
Article
em En
| MEDLINE
| ID: mdl-32987026
ABSTRACT
Women with heart failure (HF) are more symptomatic than their male counterparts. Despite deriving similar benefits from both medical and devices therapies, women continue to be underrepresented in clinic trials. Important sex-based disparities exist in enrollment in clinical trials and access to medical and device-based therapies, in part stemming from differences in medical and psychosocial comorbidities. Disparities in access to beneficial interventions likely contribute to the greater symptom burden identified in women with HF. Improved focus on the enrollment of women in clinical trials will allow a better understanding of the underpinnings of these disparities and improve the care of women with HF.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fármacos Cardiovasculares
/
Desfibriladores Implantáveis
/
Disparidades nos Níveis de Saúde
/
Terapia por Exercício
/
Disparidades em Assistência à Saúde
/
Dispositivos de Terapia de Ressincronização Cardíaca
/
Determinantes Sociais da Saúde
/
Insuficiência Cardíaca
Tipo de estudo:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article